• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非那雄胺对良性前列腺增生男性前列腺外周带和尿道周围带体积的影响。

The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia.

作者信息

Tempany C M, Partin A W, Zerhouni E A, Zinreich S J, Walsh P C

机构信息

Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland.

出版信息

Prostate. 1993;22(1):39-42. doi: 10.1002/pros.2990220106.

DOI:10.1002/pros.2990220106
PMID:7678931
Abstract

To determine the influence of androgen deprivation induced by the potent 5 alpha-reductase inhibitor finasteride on the volume of the zones of the prostate, 20 symptomatic men with established BPH were randomized to one of three groups: placebo, finasteride 1 mg, and finasteride 5 mg/day. The volume of the entire prostate gland, periurethral zone, and peripheral zone and the seminal vesicles were determined by three dimensional reconstructions of magnetic resonance contoured images of the prostate. There was no significant difference between the results achieved with 1 and 5 mg of finasteride per day; thus the results in these two groups were combined. In the placebo group there was no significant change in the volume of any structure. Following treatment for 1 year with finasteride there was a significant (P < 0.02) 17% decrease in total gland size (11.5 +/- 3.2 cc). Similarly, there was a significant (P < 0.02) 17% decrease in total gland size (11.5 +/- 3.2 cc). Similarly, there was a significant (P < 0.03) decrease in the size of the periurethral zone of the prostate (6.2 +/- 3 cc). Although there was also a decrease in the size of the peripheral zone of the prostate (2.8 +/- 1.2 cc) this did not reach statistical significance. There was no significant change in the volume of the seminal vesicles. These findings indicate for the first time that androgen deprivation induces a significant decrease in the size of the periurethral zone of the prostate in men with established BPH.

摘要

为确定强效5α-还原酶抑制剂非那雄胺诱导的雄激素剥夺对前列腺各区体积的影响,将20名已确诊良性前列腺增生(BPH)且有症状的男性随机分为三组之一:安慰剂组、1mg非那雄胺组和5mg/天非那雄胺组。通过前列腺磁共振轮廓图像的三维重建来确定整个前列腺腺体、尿道周围区、外周区以及精囊的体积。每天1mg和5mg非那雄胺的治疗结果之间无显著差异;因此将这两组的结果合并。安慰剂组中任何结构的体积均无显著变化。非那雄胺治疗1年后,腺体总体积显著(P<0.02)减小17%(11.5±3.2立方厘米)。同样,前列腺尿道周围区的大小也显著(P<0.03)减小(6.2±3立方厘米)。虽然前列腺外周区的大小也有所减小(2.8±1.2立方厘米),但未达到统计学显著性。精囊体积无显著变化。这些发现首次表明,雄激素剥夺可使已确诊BPH的男性前列腺尿道周围区的大小显著减小。

相似文献

1
The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia.非那雄胺对良性前列腺增生男性前列腺外周带和尿道周围带体积的影响。
Prostate. 1993;22(1):39-42. doi: 10.1002/pros.2990220106.
2
The clinical development of a 5 alpha-reductase inhibitor, finasteride.5α-还原酶抑制剂非那雄胺的临床研发。
J Steroid Biochem Mol Biol. 1990 Nov 20;37(3):375-8. doi: 10.1016/0960-0760(90)90487-6.
3
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.非那雄胺对良性前列腺增生男性的影响。非那雄胺研究组。
N Engl J Med. 1992 Oct 22;327(17):1185-91. doi: 10.1056/NEJM199210223271701.
4
The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia.
Prostate. 1993;22(1):31-7. doi: 10.1002/pros.2990220105.
5
The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group.5α-还原酶抑制剂非那雄胺对良性前列腺增生的临床疗效。非那雄胺研究组。
J Urol. 1992 May;147(5):1298-302. doi: 10.1016/s0022-5347(17)37547-x.
6
Finasteride: a 5 alpha-reductase inhibitor.
Clin Pharm. 1993 Jan;12(1):15-23.
7
Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia.
J Urol. 1993 Feb;149(2):342-4. doi: 10.1016/s0022-5347(17)36077-9.
8
Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.5α-还原酶抑制剂非那雄胺对人前列腺的去势样作用。
J Cell Biochem Suppl. 1992;16H:109-12. doi: 10.1002/jcb.240501225.
9
Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The Finasteride Study Group.
Prostate. 1993;22(4):291-9. doi: 10.1002/pros.2990220403.
10
Long-term urodynamic effects of finasteride in benign prostatic hyperplasia: a pilot study.非那雄胺对良性前列腺增生症的长期尿动力学影响:一项初步研究。
Eur Urol. 1993;24(1):20-6. doi: 10.1159/000474256.

引用本文的文献

1
Portulaca oleracea Extract Ameliorates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Male Sprague-Dawley Rats.马齿苋提取物改善丙酸睾酮诱导的雄性Sprague-Dawley大鼠良性前列腺增生。
Vet Med Sci. 2025 Jan;11(1):e70184. doi: 10.1002/vms3.70184.
2
Exploring the Enigma of 5-ARIs Resistance in Benign Prostatic Hyperplasia: Paving the Path for Personalized Medicine.探索良性前列腺增生中 5-ARI 耐药的奥秘:为个体化医学铺平道路。
Curr Urol Rep. 2023 Dec;24(12):579-589. doi: 10.1007/s11934-023-01188-z. Epub 2023 Nov 21.
3
Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats.
藻寡糖对去势诱导的大鼠前列腺增生的影响。
Nutrients. 2023 Jan 29;15(3):682. doi: 10.3390/nu15030682.
4
Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.配对的患者来源的 BPH 组织和正常邻近基质细胞对 3D 培养中的良性前列腺上皮细胞生长的差异影响。
Prostate. 2020 Oct;80(14):1177-1187. doi: 10.1002/pros.24044. Epub 2020 Jul 13.
5
6'-Sialyllactose Ameliorates In Vivo and In Vitro Benign Prostatic Hyperplasia by Regulating the E2F1/pRb-AR Pathway.6'-唾液乳糖通过调节 E2F1/pRb-AR 通路改善体内和体外良性前列腺增生。
Nutrients. 2019 Sep 12;11(9):2203. doi: 10.3390/nu11092203.
6
BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib.BCL-2和BCL-XL的表达在良性前列腺增生结节中下调,且不受非那雄胺和/或塞来昔布的影响。
Am J Clin Exp Urol. 2018 Feb 5;6(1):1-10. eCollection 2018.
7
CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.CD8+ T 细胞通过调节 CCL5/STAT5/CCND1 信号通路促进低雄激素水平下良性前列腺增生上皮细胞的增殖。
Sci Rep. 2017 Feb 20;7:42893. doi: 10.1038/srep42893.
8
Prostate volume growth rate changes over time: Results from men 18 to 92 years old in a longitudinal community-based study.前列腺体积增长率随时间的变化:一项基于社区的纵向研究中18至92岁男性的研究结果。
J Huazhong Univ Sci Technolog Med Sci. 2016 Dec;36(6):796-800. doi: 10.1007/s11596-016-1664-x. Epub 2016 Dec 7.
9
Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.男性患者良性前列腺增生继发下尿路症状的医学和外科治疗方式:综述
Semin Intervent Radiol. 2016 Sep;33(3):217-23. doi: 10.1055/s-0036-1586142.
10
Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.对患者组织的蛋白质组学分析显示,良性前列腺增生的基质中存在 PSA 蛋白。
Prostate. 2014 Jun;74(8):892-900. doi: 10.1002/pros.22807. Epub 2014 Apr 7.